SFC

CARDIOLOGIE PEDIATRIQUE

  • A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle [OXFORD ACADEMIC]
  • Three-dimensional printing, holograms, computational modelling, and artificial intelligence for adult congenital heart disease care: an exciting future [DOI]

CARDIO-ONCOLOGIE

  • Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review [JACC]
  • Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review [JACC]
  • Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors: A Systematic Review and Meta-Analysis [JACC]
  • Validity of Estimated Cardiorespiratory Fitness in Patients With Primary Breast Cancer [JACC]
  • Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies [JACC]

CORONAIRES ET INTERVENTIONNEL

  • Effects of Clinical Trial or Research Program Participation Status on In‐Hospital Mortality After Transcatheter Aortic Valve Implantation [AHA JOURNALS]
  • Systematic Review and Network Meta‐Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention [AHA JOURNALS]
  • Right ventricular longitudinal strain in the clinical routine: a state-of-the-art review [ACADEMIC]
  • The dysfunctional right ventricle: the importance of multi-modality imaging [ACADEMIC]
  • Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation [ACADEMIC]
  • Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience [ACADEMIC]
  • Long-term outcomes of percutaneous tricuspid annuloplasty with Cardioband device [ACADEMIC]
  • Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction [AHA JOURNALS]
  • Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) [ACADEMIC]

HTA

  • Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy [JACC]

IMAGERIE CARDIOVASCULAIRE

  • Visual Coronary and Aortic Calcium Scoring on Chest Computed Tomography Predict Mortality in Patients With Low-Density Lipoprotein-Cholesterol ≥190 mg/dL [AHA JOURNALS]
  • Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter Study [AHA JOURNALS]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure [AHA JOURNALS]
  • Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial [AHA JOURNALS]
  • Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy [AHA JOURNALS]
  • Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies [ACADEMIC]
  • Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial [ACADEMIC]

RISQUE CARDIOVASCULAIRE

  • Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial [JAMA NETWORK]
  • Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization [JAMA NETWORK]

RYTHMOLOGIE

  • Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery [JACC]
  • Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week [JACC]
  • Rivaroxaban Monotherapy vs Combination Therapy on Thrombotic and Bleeding Events in Atrial Fibrillation [JAMA NETWORK]
  • Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial [ACADEMIC]
  • Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial [AHA JOURNALS]
  • First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial [AHA JOURNALS]
  • Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial [AHA JOURNALS]
  • Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation [AHA JOURNALS]

USIC

  • Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database [AHA JOURNALS]
  • Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes [AHA JOURNALS]

VALVULOPATHIES

  • Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review [JAMA NETWORK]
  • Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair [SCIENCE DIRECT]

COVID

  • Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities [JAMA NETWORK]
  • The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid [JAMA NETWORK]
  • COVID-19 in 2022—The Beginning of the End or the End of the Beginning? [JAMA NETWORK]

LA FRANCE A L’HONNEUR

  • Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Tribouilloy C, Bohbot Y, Kubala M, Ruschitzka F, Popescu B, Wendler O, Laroche C, Bartha E, Ince H, Simakova I, Vahanian A, Iung B. [SCIENCE DIRECT]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !